Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses

Y Chao, C Liang, H Tao, Y Du, D Wu, Z Dong, Q Jin… - Science …, 2020 - science.org
Currently, there is a huge demand to develop chemoimmunotherapy with reduced systemic
toxicity and potent efficacy to combat late-stage cancers with spreading metastases. Here …

Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses.

Y Chao, C Liang, H Tao, Y Du, D Wu, Z Dong… - Science …, 2020 - europepmc.org
Currently, there is a huge demand to develop chemoimmunotherapy with reduced systemic
toxicity and potent efficacy to combat late-stage cancers with spreading metastases. Here …

[引用][C] Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses

Y Chao, C Liang, H Tao, Y Du, D Wu… - Science …, 2020 - ui.adsabs.harvard.edu
Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic
antitumor immune responses - NASA/ADS Now on home page ads icon ads Enable full ADS …

Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses

Y Chao, C Liang, H Tao, Y Du, D Wu… - Science …, 2020 - pubmed.ncbi.nlm.nih.gov
Currently, there is a huge demand to develop chemoimmunotherapy with reduced systemic
toxicity and potent efficacy to combat late-stage cancers with spreading metastases. Here …

[HTML][HTML] Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses

Y Chao, C Liang, H Tao, Y Du, D Wu, Z Dong… - Science …, 2020 - ncbi.nlm.nih.gov
Currently, there is a huge demand to develop chemoimmunotherapy with reduced systemic
toxicity and potent efficacy to combat late-stage cancers with spreading metastases. Here …

Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses.

Y Chao, C Liang, H Tao, Y Du, D Wu, Z Dong… - Science …, 2020 - europepmc.org
Currently, there is a huge demand to develop chemoimmunotherapy with reduced systemic
toxicity and potent efficacy to combat late-stage cancers with spreading metastases. Here …